Advertisement
Advertisement
MAIA
MAIA Biotechnology, Inc.
1.42
USDSponsored
0.00
0.00%
Aug 07, 15:59 UTC -4
Closed
Pre-Market
1.41
-0.01
-0.63%
MAIA Earnings Reports
Positive Surprise Ratio
MAIA beat 10 of 14 last estimates.
71%
Next Report
Today
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.11
Implied change from Q1 26 (Revenue/ EPS)
--
/-21.43%
Implied change from Q2 25 (Revenue/ EPS)
--
/-38.89%
MAIA Biotechnology, Inc. earnings per share and revenue
On May 11, 2026, MAIA reported earnings of -0.14 USD per share (EPS) for Q1 26, beating the estimate of -0.18 USD, resulting in a 23.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.76% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an decrease of -21.43% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$2.09
Actual
$2.21
Surprise
+5.69%
Corvus Pharmaceuticals, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.16
Actual
-$0.19
Surprise
-17.36%
CytomX Therapeutics, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-13.78%
Prothena Corporation plc Ordinary Shares
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.32
Surprise
+19.76%
Entera Bio Ltd. Ordinary Shares
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.14
Surprise
-71.57%
BioMarin Pharmaceuticals Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.70
Actual
$1.20
Surprise
+71.04%
Axsome Therapeutics, Inc
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.86
Actual
-$0.99
Surprise
-14.90%
Praxis Precision Medicines, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$3.73
Actual
-$2.87
Surprise
+23.14%
Ligand Pharmaceuticals Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.90
Actual
$2.37
Surprise
+24.56%
Trevi Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+2.22%
FAQ
What were MAIA Biotechnology, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, MAIA Biotechnology, Inc. reported EPS of -$0.14, beating estimates by 23.75%, and revenue of $0.00, 0% as expectations.
How did the market react to MAIA Biotechnology, Inc.'s Q1 2026 earnings?
The stock price moved down -0.76%, changed from $1.32 before the earnings release to $1.31 the day after.
When is MAIA Biotechnology, Inc. expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for MAIA Biotechnology, Inc.'s next earnings report?
Based on 3
analysts, MAIA Biotechnology, Inc. is expected to report EPS of -$0.11 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement